185 related articles for article (PubMed ID: 29174670)
1. Neuroleptic malignant syndrome (NMS) associated with amisulpride and sertraline use: A case report and discussion.
Uvais NA; Gangadhar P; Sreeraj VS; Rafeeque PA
Asian J Psychiatr; 2019 Mar; 41():82-83. PubMed ID: 29174670
[No Abstract] [Full Text] [Related]
2. Neuroleptic malignant syndrome following combination of sertraline and paroxetine: a case report.
Uguz F; Sonmez EÖ
Gen Hosp Psychiatry; 2013; 35(3):327.e7-327.e8. PubMed ID: 23312145
[TBL] [Abstract][Full Text] [Related]
3. Forme fruste of neuroleptic malignant syndrome associated with the use of sertraline.
Miranda M; Soto F; Fischman P
Parkinsonism Relat Disord; 2011 Mar; 17(3):217-8. PubMed ID: 21147016
[No Abstract] [Full Text] [Related]
4. Putative neuroleptic malignant syndrome associated with sertraline withdrawal.
Konstantakopoulos G; Kouzoupis AV; Papageorgiou SG; Oulis P
J Clin Psychopharmacol; 2009 Jun; 29(3):300-1. PubMed ID: 19440088
[No Abstract] [Full Text] [Related]
5. Possible neuroleptic malignant syndrome with aripiprazole and fluoxetine.
Duggal HS; Kithas J
Am J Psychiatry; 2005 Feb; 162(2):397-8. PubMed ID: 15677611
[No Abstract] [Full Text] [Related]
6. Neuroleptic malignant syndrome induced by quetiapine and fluvoxamine.
Matsumoto R; Kitabayashi Y; Nakatomi Y; Tsuchida H; Fukui K
Am J Psychiatry; 2005 Apr; 162(4):812. PubMed ID: 15800166
[No Abstract] [Full Text] [Related]
7. Amenorrhea after sertraline introduction in an amisulpride-treated patient with undiagnosed polycystic ovary disease.
Peritogiannis V; Goulia P; Pappas D; Hyphantis T; Mavreas V
J Clin Psychopharmacol; 2007 Apr; 27(2):235-7. PubMed ID: 17414262
[No Abstract] [Full Text] [Related]
8. Amisulpride and neuroleptic malignant syndrome.
Tu MC; Hsiao CC
Chang Gung Med J; 2011; 34(5):536-40. PubMed ID: 22035899
[TBL] [Abstract][Full Text] [Related]
9. [Neuroleptic malignant syndrome associated with olanzapine].
García López MM; Ciprés L; de Cendra E; Vilalta Franch J
Med Clin (Barc); 1999 Sep; 113(6):239. PubMed ID: 10472615
[No Abstract] [Full Text] [Related]
10. [Malignant neuroleptic syndrome in treatment with the new, atypical antipsychotic agents, risperidone and olanzapine].
Gram LF
Ugeskr Laeger; 2000 Mar; 162(13):1914-5. PubMed ID: 10765710
[No Abstract] [Full Text] [Related]
11. Hyperpigmentation with amisulpride.
Mendhekar DN
Aust N Z J Psychiatry; 2009 Jan; 43(1):88. PubMed ID: 19086350
[No Abstract] [Full Text] [Related]
12. Serotonin reuptake inhibitor provoked recurrence of alcohol hallucinosis--remission with additive amisulpride medication. A case report.
Hermann D; Heinz A; Croissant B; Mann K
Pharmacopsychiatry; 2004 Mar; 37(2):90-2. PubMed ID: 15048618
[No Abstract] [Full Text] [Related]
13. [Drug-induced neuroleptic malignant syndrome].
Jitsuiki H; Yamashita H; Kozuru T; Yamawaki S
Nihon Naika Gakkai Zasshi; 2007 Aug; 96(8):1627-33. PubMed ID: 17802712
[No Abstract] [Full Text] [Related]
14. Genotype A1/A2 associated with neuroleptic malignant syndrome.
Del Tacca M; Lattanzi L; Lastella M; Di Paolo A; Mungai F; Danesi R; Menichetti F; Dell'osso L; Cassano GB
Bipolar Disord; 2005 Aug; 7(4):390-1. PubMed ID: 16026494
[No Abstract] [Full Text] [Related]
15. Quetiapine plus SSRI in treatment-resistant depression: possible mechanisms.
Devarajan S; Ali J; Dursun SM
Psychopharmacology (Berl); 2006 Apr; 185(3):402-3. PubMed ID: 16538471
[No Abstract] [Full Text] [Related]
16. Association between selective serotonin-reuptake inhibitors, second-generation antipsychotics, and neuroleptic malignant syndrome.
Stevens DL
Ann Pharmacother; 2008 Sep; 42(9):1290-7. PubMed ID: 18628446
[TBL] [Abstract][Full Text] [Related]
17. Severe acute pancreatitis, neuroleptic malignant syndrome and grand mal seizures associated with elevated amisulpride and low clozapine serum levels.
Bonnet U; Taazimi B; Montag M; Ronge R; Gespers H; Kuhlmann R; Grabbe D; Jahn J
Psychiatr Danub; 2015 Dec; 27(4):424-5. PubMed ID: 26609657
[No Abstract] [Full Text] [Related]
18. [Sertraline. Adverse effects due to the superposition of serotonic and malignant neuroleptic syndromes].
López Gastón OD; Wierzbinsky S; López Gastón RS; Resnik S; Pardoménico S; Jorge M
Medicina (B Aires); 2000; 60(2):241-4. PubMed ID: 10962817
[TBL] [Abstract][Full Text] [Related]
19. Hypomania associated with mirtazapine augmentation of sertraline.
Soutullo CA; McElroy SL; Keck PE
J Clin Psychiatry; 1998 Jun; 59(6):320. PubMed ID: 9671349
[No Abstract] [Full Text] [Related]
20. Neuroleptic malignant syndrome: a diagnosis easily missed.
McDonough CM; Swift G; Managan B; Sheehan JD
Ir Med J; 2000; 93(5):152-4. PubMed ID: 11072926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
